Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C

4.5 (449) ·
$ 8.99 ·
In stock

Description

Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Cancer nanomedicine for combination cancer immunotherapy
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Molecular and nanoengineering approaches towards activatable cancer immunotherapy - Chemical Society Reviews (RSC Publishing) DOI:10.1039 /C9CS00773C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy - Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Trident Molecule with Nanobrush–Nanoparticle–Nanofiber Transition Property Spatially Suppresses Tumor Metastasis
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
New approaches to molecular cancer therapeutics
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Enhancing cancer immunotherapy with nanomedicine
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Supramolecular cancer nanotheranostics - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS00011F
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy -  Materials Horizons (RSC Publishing) DOI:10.1039/D0MH00715C
Molecules, Free Full-Text

Related products

You may also like

copyright © 2019-2024 computerav.com all rights reserved.